Literature DB >> 14715471

Oxidized lipoproteins, beta amyloid peptides and Alzheimer's disease.

A Y Sun1, B Draczynska-Lusiak, G Y Sun.   

Abstract

Recent studies have provided strong evidence for the involvement of oxidative stress in the pathogenesis of Alzheimer's disease (AD) and beta-amyloid peptides (ABeta) have been implicated to play an important role in mediating these oxidative events. Lipoproteins (LP) in the brain are likely targets of oxidative insult and together enhance ABeta -mediated toxicity to neurons. We hypothesize that uptake of oxidized LP by neuron leads to an acceleration of the intracellular oxidative pathways and exacerbation of neuron cell death. In our previous studies, we demonstrated the ability of oxidized low-density LP from plasma to induce cell death in PC12 cells. In this study, a synthetic LP fraction was prepared using lipids extracted from rat brain and incubated with albumin and apoE. This brain lipid-derived LP (BLP) was subjected to oxidation by incubation with Fe(3+)and subsequently tested with primary cortical neurons in culture. To study uptake of the BLP, native and oxidized BLP containing apoE3 or apoE4 were labeled with [(14)C]cholesterol or the fluorescent probe 3,3-dioctadecylindo-carbocyanine (Di-I) prior to exposing to cultured neurons. Results showed that regardless of the labeling method, oxidized BLP were more effectively taken up by the neurons than the native BLP. Cell viability was assessed by assaying the release of lactate dehydrogenase (LDH) into the medium and by determining the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), an agent depicting mitochondrial activity. While exposure of neurons to oxidized BLP and aggregated ABeta (1-42) alone could result in MTT reduction (24%), greater reduction (40%) could be observed when oxidized LP was added together with ABeta. Neuronal cell death due to oxidized BLP could be ameliorated by resveratrol, a polyphenolic compound known for its antioxidant properties. Taken together, these results are in agreement with the notion that ABeta and oxidized BLP can synergistically enhance oxidative damage in neurons and antioxidants such as resveratrol can ameliorate these damages.

Entities:  

Year:  2001        PMID: 14715471     DOI: 10.1007/bf03033189

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  49 in total

1.  Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.

Authors:  C N Bassett; M D Neely; K R Sidell; W R Markesbery; L L Swift; T J Montine
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

2.  Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.

Authors:  A M Cataldo; J L Barnett; C Pieroni; R A Nixon
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

3.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

4.  4-hydroxynonenal increases neuronal susceptibility to oxidative stress.

Authors:  J N Keller; K B Hanni; W R Markesbery
Journal:  J Neurosci Res       Date:  1999-12-15       Impact factor: 4.164

5.  Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents.

Authors:  P C Rensen; R M Schiffelers; A J Versluis; M K Bijsterbosch; M E Van Kuijk-Meuwissen; T J Van Berkel
Journal:  Mol Pharmacol       Date:  1997-09       Impact factor: 4.436

Review 6.  The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease.

Authors:  U Beffert; M Danik; P Krzywkowski; C Ramassamy; F Berrada; J Poirier
Journal:  Brain Res Brain Res Rev       Date:  1998-07

7.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Authors:  W J Strittmatter; K H Weisgraber; D Y Huang; L M Dong; G S Salvesen; M Pericak-Vance; D Schmechel; A M Saunders; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats.

Authors:  J Poirier; A Baccichet; D Dea; S Gauthier
Journal:  Neuroscience       Date:  1993-07       Impact factor: 3.590

9.  Expression of apolipoprotein E during nerve degeneration and regeneration.

Authors:  M J Ignatius; P J Gebicke-Härter; J H Skene; J W Schilling; K H Weisgraber; R W Mahley; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

10.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more
  5 in total

Review 1.  SIRT1 in neurodevelopment and brain senescence.

Authors:  A Zara Herskovits; Leonard Guarente
Journal:  Neuron       Date:  2014-02-05       Impact factor: 17.173

2.  Pinocembrin Attenuates Mitochondrial Dysfunction in Human Neuroblastoma SH-SY5Y Cells Exposed to Methylglyoxal: Role for the Erk1/2-Nrf2 Signaling Pathway.

Authors:  Marcos Roberto de Oliveira; Alessandra Peres; Gustavo Costa Ferreira
Journal:  Neurochem Res       Date:  2016-12-21       Impact factor: 3.996

Review 3.  Resveratrol and Alzheimer's Disease: Mechanistic Insights.

Authors:  Touqeer Ahmed; Sehrish Javed; Sana Javed; Ameema Tariq; Dunja Šamec; Silvia Tejada; Seyed Fazel Nabavi; Nady Braidy; Seyed Mohammad Nabavi
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

Review 4.  Understanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN.

Authors:  Qinyuan Xu; Sijia Cao; Sanjeeva Rajapakse; Joanne A Matsubara
Journal:  Lipids Health Dis       Date:  2018-01-04       Impact factor: 3.876

Review 5.  Sirtuin deacetylases in neurodegenerative diseases of aging.

Authors:  Adrianna Z Herskovits; Leonard Guarente
Journal:  Cell Res       Date:  2013-05-21       Impact factor: 25.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.